Free provider profile
DAVID WOLFF, M.D.
NPI 1699971200
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2018-04-10.
615 HOPE RD STE 2, EATONTOWN, NJ, 07724
732-389-4482
2 practice locations listed
Enumerated 2007-06-21
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 2 practice locations listed — multi-site footprint.
- — Record last updated 8 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
371
Medicare patients
35
Part D drug cost
$31,613
Brand-name share
4.3%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Methylphenidate Er (Methylphenidate Hcl) | 23 | $2,801 |
| Bupropion Hcl Sr (Bupropion Hcl) | 14 | $542 |
| Trazodone Hcl (Trazodone Hcl) | 13 | $508 |
| Bupropion Xl (Bupropion Hcl) | 11 | $339 |
| Alprazolam (Alprazolam) | 72 | $324 |
| Clonazepam (Clonazepam) | 19 | $295 |
| Zolpidem Tartrate (Zolpidem Tartrate) | 22 | $290 |
| Buspirone Hcl (Buspirone Hcl) | 18 | $252 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024311 sessions · 22 patients · $264,509
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.